Collectively, our study suggests that skimmianine may alleviate cerebral ischemia/reperfusion injury by modulating immune and inflammatory responses, as well as antioxidant mechanisms mediated by IBA-1, IL-6, and NF-κB. The gene discussed is AIF1; the disease is brain ischemia.